| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/23/2022 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 12.5k | $1.60 | $20k | | 06/23/2022 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 12.5k | $11.74 | $146.8k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 7k | $11.88 | $83.2k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 7k | $9.22 | $64.5k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Common Stock | 9k | $8.50 | $76.5k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 18k | $25.38 | $456.8k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 9k | $21.85 | $196.6k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 12.5k | $13.83 | $172.9k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 12.5k | $20.16 | $252k | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 12.5k | $28.14 | $351.8k | | 11/19/2021 |
| 06/24/2021 | Flexion Therapeutics Inc | FLXN | Grant | Common Stock | 4.5k | $0.00 | $0 | | 06/24/2021 |
| 06/24/2021 | Flexion Therapeutics Inc | FLXN | Grant | Stock option (right to buy) | 7k | $9.22 | $64.5k | | 06/24/2021 |
| 06/16/2021 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 12.5k | $16.55 | $206.9k | | 06/16/2021 |
| 12/11/2020 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 25k | $26.00 | $650k | | 12/11/2020 |
| 12/11/2020 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 25k | $26.00 | $650k | | 12/11/2020 |
| 10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Restricted Stock Unit | 3.7k | $0.00 | $0 | | 10/23/2020 |
| 10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Stock Option (Right to Buy) | 155.3k | $0.00 | $0 | | 10/23/2020 |
| 10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Common Stock | 13.5k | $0.00 | $0 | | 10/23/2020 |
| 06/18/2020 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 6.5k | $33.62 | $219.9k | | 06/18/2020 |
| 06/18/2020 | IMMUNOMEDICS INC | IMMU | Grant | Common Stock, $0.01 par value per share | 3.7k | $0.00 | $0 | | 06/18/2020 |
| 06/10/2020 | Flexion Therapeutics Inc | FLXN | Grant | Stock option (right to buy) | 7k | $11.88 | $83.2k | | 06/10/2020 |
| 06/10/2020 | Flexion Therapeutics Inc | FLXN | Grant | Common Stock | 4.5k | $0.00 | $0 | | 06/10/2020 |
| 06/19/2019 | Flexion Therapeutics Inc | FLXN | Grant | Stock option (right to buy) | 12.5k | $11.74 | $146.8k | | 06/19/2019 |
| 06/07/2019 | IMMUNOMEDICS INC | IMMU | Grant | Common Stock, $0.01 par value per share | 9.7k | $0.00 | $0 | | 06/07/2019 |
| 06/07/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 17.1k | $12.93 | $220.8k | | 06/07/2019 |
| 06/06/2019 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/06/2019 |
| 06/06/2019 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 20.1k | $4.23 | $85k | | 06/06/2019 |
| 03/08/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 22.9k | $16.35 | $373.7k | | 03/05/2019 |
| 03/05/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 79.8k | $16.96 | $1.4M | | 03/05/2019 |
| 06/20/2018 | Flexion Therapeutics Inc | FLXN | Grant | Stock option (right to buy) | 12.5k | $28.14 | $351.8k | | 06/20/2018 |
| 06/14/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $11.14 | $139.2k | | 06/14/2018 |
| 06/08/2018 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 12.7k | $2.50 | $31.8k | | 06/08/2018 |
| 04/02/2018 | IMMUNOMEDICS INC | IMMU | Grant | Common Stock, $0.01 par value per share | 3.8k | $0.00 | $0 | | 04/02/2018 |
| 04/02/2018 | IMMUNOMEDICS INC | IMMU | Grant | Stock Options (right to buy) | 6.5k | $14.29 | $92.8k | | 04/02/2018 |
| 10/26/2017 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $1.32 | $19.8k | | 10/26/2017 |
|